D-Cycloserine (DCS): Clinical Trials

7 trials of D-Cycloserine (DCS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 6 Phase 2, 2 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 2, Not yet recruiting 2, Active not recruiting 1, Recruiting 1
Phase 12Completed 1, Recruiting 1
Early Phase 11Recruiting 1

Follow D-Cycloserine (DCS): new trials by email Literature Review of D-Cycloserine (DCS) trials Research Report on D-Cycloserine (DCS)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ONE-P TMS Military Veterans
D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS) - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingFidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA502026-11-012026-08-20
ONE-P TMS First Responders
D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS) - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingFidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA502026-11-012026-08-19
A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder
TMS, D-Cycloserine (DCS) - Borderline Personality Disorder (BPD)
Phase 1 / Phase 2RecruitingMclean Hospital202026-06-102026-08-05
Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
D-Cycloserine (DCS), Continuous theta-burst stimulation (cTBS), Transcranial Magnetic Stimulation Sham - Major Depression
Early Phase 1RecruitingMclean Hospital802026-03-112026-05-13
Novel and Conventional Interventions for Cognitive and Emotional Flexibility in Patient Trauma
D-Cycloserine (DCS), Transcranial Magnetic Stimulation, Unified Protocol - Depression, Anxiety
Phase 2Active not recruitingMclean Hospital752025-06-012026-10-09
D-cycloserine and Treatment of Feeding Disorders
Behavioral Intervention, d-cycloserine (DCS), Placebo - Feeding Disorders, Specific Phobia
Phase 1 / Phase 2CompletedEmory University162013-03-012014-10-23
D-Cycloserine Facilitation of Cocaine - Cue Extinction
D-Cycloserine (DCS), Placebo - Cocaine Use Disorders
Phase 2CompletedMedical University of South Carolina792008-09-012016-04-13

Conditions studied

Combat Disorders (2)  ·  Depression (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Anxiety Disorders (1)  ·  Borderline Personality Disorder (1)  ·  Depressive Disorder, Major (1)  ·  Feeding and Eating Disorders (1)  ·  Phobia, Specific (1)  ·  Psychological Well-Being (1)  ·  Substance-Related Disorders (1)

Sponsors

Mclean Hospital (3)  ·  Fidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA (2)  ·  Emory University (1)  ·  Medical University of South Carolina (1)

Countries

United States (5)  ·  Canada (2)

Top investigators

Fidel Vila-Rodriguez, M.D., PhD, FRCPC, DFAPA (2)  ·  Jenna M Traynor, PhD (1)  ·  Joshua Brown, MD, PhD (1)  ·  Joshua C Brown, MD, PhD (1)  ·  Kathleen T Brady, M.D., Ph.D. (1)  ·  William G Sharp, Ph.D. (1)

Results publications

PMID 23497788, PMID 24938849

NIH funding

R01DA023188 (1), R01MH139697 (1)